BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8708730)

  • 21. In vitro comparative antileukemic activity of various glucocorticoids in childhood acute leukemia.
    Styczyński J; Wysocki M; Balwierz W; Rokicka-Milewska R; Matysiak M; Balcerska A; Kowalczyk A; Wachowiak J; Sońta-Jakimczyk D; Chybicka A
    Neoplasma; 2002; 49(3):178-83. PubMed ID: 12098004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
    Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
    Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.
    Kaspers GJ; Pieters R; Van Zantwijk CH; Van Wering ER; Van Der Does-Van Den Berg A; Veerman AJ
    Blood; 1998 Jul; 92(1):259-66. PubMed ID: 9639525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential antileukemic activity of prednisolone and dexamethasone in freshly isolated leukemic cells.
    Mihál V; Hajdúch M; Nosková V; Feketová G; Jess K; Gojová L; Kaspárek I; Starý J; Blazek B; Pospísilová D; Novák Z
    Adv Exp Med Biol; 1999; 457():461-71. PubMed ID: 10500823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro resistance of leukaemic blasts to prednisolone in bcr-abl positive childhood acute lymphoblastic leukaemia.
    Gupta M; Kumar A; Dabadghao S
    Indian J Med Res; 2002 Dec; 116():268-72. PubMed ID: 12807155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia.
    Manabe A; Coustan-Smith E; Behm FG; Raimondi SC; Campana D
    Blood; 1992 May; 79(9):2370-7. PubMed ID: 1373973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
    Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
    Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis.
    Styczynski J; Koltan A; Wysocki M
    Neoplasma; 2006; 53(2):168-73. PubMed ID: 16575474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia.
    Schwartz CL; Thompson EB; Gelber RD; Young ML; Chilton D; Cohen HJ; Sallan SE
    J Clin Oncol; 2001 Feb; 19(4):1040-6. PubMed ID: 11181667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thalidomide increases in vitro sensitivity of childhood acute lymphoblastic leukemia cells to prednisolone and cytarabine.
    Czyzewski K; Zaborowska A; Styczyński J
    Arch Immunol Ther Exp (Warsz); 2006; 54(5):341-5. PubMed ID: 17031469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein.
    Campana D; Coustan-Smith E; Manabe A; Buschle M; Raimondi SC; Behm FG; Ashmun R; Aricò M; Biondi A; Pui CH
    Blood; 1993 Feb; 81(4):1025-31. PubMed ID: 8427984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-resistance to five glucocorticoids in childhood acute lymphoblastic and non-lymphoblastic leukemia samples tested by the MTT assay: preliminary report.
    Styczyński J; Wysocki M; Debski R; Balwierz W; Rokicka-Milewska R; Matysiak M; Balcerska A; Kowalczyk J; Wachowiak J; Sońta-Jakimczyk D; Chybicka A
    Acta Biochim Pol; 2002; 49(1):93-8. PubMed ID: 12136961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
    Hulleman E; Kazemier KM; Holleman A; VanderWeele DJ; Rudin CM; Broekhuis MJ; Evans WE; Pieters R; Den Boer ML
    Blood; 2009 Feb; 113(9):2014-21. PubMed ID: 18978206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of BAX and BCL-2 Gene Expression and Apoptosis Induction in Acute Lymphoblastic Leukemia Cell Line CCRFCEM after High- Dose Prednisolone Treatment.
    Ghasemi A; Khanzadeh T; Zadi Heydarabad M; Khorrami A; Jahanban Esfahlan A; Ghavipanjeh S; Gholipour Belverdi M; Darvishani Fikouhi S; Darbin A; Najafpour M; Azimi A
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2319-2323. PubMed ID: 30141309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ex vivo modulation of response to prednisolone in childhood acute lymphoblastic leukaemia.
    Styczynski J; Wysocki M
    Br J Haematol; 2006 May; 133(4):397-9. PubMed ID: 16643446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paucity of leukemic progenitor cells in the bone marrow of pediatric B-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
    Uckun FM; Gaynon PS; Stram DO; Sensel MG; Sarquis MB; Lazarus KH; Willoughby M
    Clin Cancer Res; 1999 Sep; 5(9):2415-20. PubMed ID: 10499612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological and clinical significance of in vitro prednisolone resistance in adult acute lymphoblastic leukaemia.
    Tosi P; Visani G; Ottaviani E; Manfroi S; Tura S
    Eur J Haematol; 1996 Aug; 57(2):134-41. PubMed ID: 8856090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor.
    Bachmann PS; Gorman R; Mackenzie KL; Lutze-Mann L; Lock RB
    Blood; 2005 Mar; 105(6):2519-26. PubMed ID: 15572593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia.
    Jiang N; Koh GS; Lim JY; Kham SK; Ariffin H; Chew FT; Yeoh AE
    Exp Hematol; 2011 Mar; 39(3):321-9, 329.e1-3. PubMed ID: 21130142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.